Skip to main content
Critical Care Explorations logoLink to Critical Care Explorations
. 2026 Feb 13;8(2):e1364. doi: 10.1097/CCE.0000000000001364

Immediate Postoperative Evolution of Cerebral Doppler and Saturation Parameters After Cardiopulmonary Bypass in Infants With Congenital Heart Disease: A Prospective Cohort Study

Marina Mir 1,2,3,, Guillaume Maitre 4, Adrian Dancea 5,6, Pierre-Luc Bernier 7,8, Patricia Fontela 9, Samara Zavalkoff 9, Ana Roche Martínez 3,10, Nicole O’Brien 11, Kerri L LaRovere 12, Sam D Shemie 9, Gabriel Altit 13
PMCID: PMC12908801  PMID: 41686139

Abstract

OBJECTIVES:

To describe temporal trends and instantaneous relationships between middle cerebral artery (MCA) cerebral blood flow velocity, cerebral oxygen saturation (Csat), cerebral fractional tissue oxygen extraction (cFTOE), and systemic arteriovenous oxygen difference (AVo2) during the first 24 hours following congenital heart disease (CHD) surgery requiring cardiopulmonary bypass (CPB).

DESIGN:

Prospective observational study conducted from August 2021 to June 2022.

SETTING:

Single-center pediatric cardiac ICU in Canada.

PATIENTS:

Fifteen ventilated neonates and infants admitted to the PICU following CHD surgery requiring CPB.

INTERVENTIONS:

None.

MEASUREMENTS AND MAIN RESULTS:

Bilateral transcranial Doppler (TCD) assessments of the MCA were performed at seven predefined time points during the first 24 hours following CPB, with time 0 defined as the end of CPB. A total of 87 simultaneous measurements of systemic oxygen saturation, Csat, TCD-derived parameters, and AVo2 were analyzed. The nadir in MCA velocities occurred at a mean of 9.3 hours (sd, 1.7 hr) post-CPB and coincided with the lowest Csat and the highest AVo2 difference and cFTOE. Lower MCA mean velocities were associated with higher AVo2 difference and increased cFTOE.

CONCLUSIONS:

In neonates and infants following CPB, MCA velocities reach its lowest point approximately 9 hours post-CPB, coinciding with the highest AVo2 difference and previously published nadir of cardiac output. These findings could suggest a period of relative cerebral hypoperfusion. Future studies should evaluate whether targeted interventions guided by multimodal cerebral monitoring can mitigate the risk of acute and long-term brain injury in this vulnerable population.

Keywords: cerebral blood flow, cerebral saturation, congenital heart defect, near-infrared spectroscopy, pediatric intensive care unit, transcranial Doppler sonography


KEYPOINTS.

Question: Are transcranial Doppler and near-infrared spectroscopy able to noninvasively detect low cardiac output syndrome in infants after congenital heart disease (CHD) repair?

Findings: In this prospective pilot study, infants with CHD after cardiopulmonary bypass (CPB), the nadir of cerebral saturations (CSat) and cerebral blood flow velocities (CBFv) occur 6–10 hours after CPB, similar than previously reported nadir of cardiac index. The nadir of CBFv and CSat occurred during the peak of arteriovenous oxygen difference.

Meaning: Monitoring CBFv and CSat after CPB can provide noninvasive information on cardiac output and promptly detect suboptimal cerebral perfusion.

Low cardiac output syndrome (LCOS) is a frequent complication observed in 25% of children after cardiac surgery (1), typically occurring 6–18 hours after the surgical intervention (2, 3). Early recognition and management of LCOS in post-cardiac surgery pediatric patients is essential to reduce mortality and morbidity (4). Invasive and continuous cardiac output (CO) monitoring is the gold standard to diagnose LCOS, however, is not routinely performed in children. Pediatric intensivists rely on clinical evaluation and indirect parameters of low CO such as heart rate, blood pressure, urine output, lactate, and arteriovenous oxygen difference (AVo2) (5), which are insufficient to detect cerebral hypoperfusion. Technologies such as transcranial Doppler (TCD) and cerebral near-infrared spectroscopy (NIRS) (6) could help detect LCOS and brain hypoperfusion, and guide personalized brain-targeted care, potentially improving long-term neurologic outcomes.

TCD can measure cerebral blood flow velocities (CBFv) as a surrogate of cerebral blood flow (7, 8). TCD has been used during cardiopulmonary bypass (CPB) in pediatric patients (912). Due to impaired cerebrovascular autoregulation during CPB, arterial blood pressure and mean CBFv become correlated, suggesting that TCD can be used to adjust CPB pump flow to patient needs (13, 14). TCD may also aid in the detection of intraoperative cerebral emboli during CPB (15). Data on the evolution of CBFv in the postoperative cardiac setting in still lacking.

NIRS is employed not only as a cerebral oxygen monitor but also to assess adequacy of cerebral perfusion (12). To date, the observed correlations between NIRS, systemic hemodynamics, and pump flow have been limited (12). Cerebral saturation (CSat) trends measured by NIRS during cardiac surgery have been correlated with invasive central venous oxygen saturation using internal jugular vein blood gas oximetry (16). Low CSat in the immediate postoperative period has been associated with brain injury and neurodevelopmental impairment (17, 18).

Currently, there is limited data on CBF indices obtained via TCD and NIRS in the immediate postoperative period for infants undergoing cardiac surgery with CPB. We aimed to characterize the physiologic evolution and correlation of the middle cerebral artery (MCA) CBFv and bilateral CSat in this population.

Our long-term goal is to identify modifiable risk factors for poor neurologic outcome, investigate potential treatment approaches, and ultimately improve outcomes in neonates with congenital heart disease (CHD) undergoing cardiac surgery with CPB.

MATERIALS AND METHODS

Study Population

This was a prospective, single-center observational cohort study recruiting infants admitted to the PICU after congenital heart surgery between August 2021 and June 2022. The study population included infants 37 weeks old or older, corrected gestational age, and 12 months young or younger, sedated, ventilated, and admitted following cardiac surgery requiring CPB. Exclusion criteria were a history of intracranial bleed or stroke, or an expected death within 24 hours of admission. We included two participants with univentricular circulation as we aimed to evaluate trends over time, independent of the present or absence of intracardiac shunts. A participant (case 1) unexpectedly died a few hours after surgery. Although expected deaths within 24 hours were excluded, this participant’s death was not anticipated, so they were included in the study. “Time 0” refers to the moment when the participant was disconnected from the CPB intraoperatively. Patient demographic and clinical information were extracted from medical charts. Central venous saturation was sampled in the superior vena cava in 13 of 15 participants and in the right atrium in two of 15 participants that had no postoperative intracardiac shunt. Concurrent NIRS, TCD evaluations, and blood gas values were collected. Data collection was finished when patient reached 24 hours after the end of bypass or when patient was extubated, whichever came first. Critically ill extubated and nonsedated pediatric patients might exhibit different CBFv values compared with when they are intubated and sedated. This study was reviewed and approved by the McGill University Health Centre Research Ethics Board Pediatrics Panel on August 10, 2021 (MP-2022-7831, Use of near-infrared spectroscopy and transcranial Doppler in pediatric patients with low cardiac output syndrome after congenital heart surgery—a prospective cohort pilot study). Informed consent was obtained from their legal guardians before data collection. Procedures followed were in accordance with the Helsinki Declaration of 1975.

MCA Doppler

A single experienced operator (M.M.) conducted serial TCD of bilateral MCAs using a 1–4 MHz sector array probe with a Philips Sparq ultrasound system (Bothell, WA). The protocol followed adhered to expert consensus recommendations (7). At each time point, three pulse wave Doppler measurements of both MCAs were performed and repeated approximately every 4 hours from the time of admission up to 24 hours after CPB. An additional TCD measurement was performed if a clinical trigger was present, such as acute cerebral desaturation greater than 10%, acute mean arterial pressure drop of greater than 10 mm Hg, sustained tachycardia greater than 30 beats/min above baseline, etc (Supplemental Table 1, https://links.lww.com/CCX/B598). Data extracted from TCD included peak systolic velocity (PSV), end-diastolic velocity (EDV), and mean velocity (MV; Supplemental Fig. 1, https://links.lww.com/CCX/B598). The resistive index (RI) of the MCAs was calculated using the formula (PSV–EDV)/PSV. In the absence of diastolic flow, diastolic velocity was considered zero. The pulsatility index (PI) of the MCA was calculated using the formula (PSV–EDV)/MV (19). The sonographer was unblinded to blood gas results and CSat. Concurrent arterial and venous gas sampling were conducted, and the AVo2 was calculated.

Cerebral and Peripheral Saturations

CSat for all participants were measured by NIRS using the INVOS 5100C cerebral/somatic oximeter (Medtronic, Minneapolis, MN) equipped with bilateral sensors. Right and left frontal CSat were collected at arrival in the PICU and concomitantly at each blood sampling and TCD. Right upper limb oxygen saturation (Spo2), measured with a (Masimo Corporation, Irvine, CA) SET Pulse Oximeter, was recorded to calculate the corresponding cerebral fractional tissue oxygen extraction (cFTOE) with the formula: (Spo2–CSat)/Spo2 × 100 (20).

Statistics

We used descriptive statistics, including means (sds) and medians (interquartile ranges [IQRs]) for continuous variables, and counts (proportions) for categorical variables. We built random mixed-effects models with random slopes and intercepts to evaluate CSat, cFTOE, AVo2, VM-MCA, RI-MCA, and PI-MCA. These models included the time since the end of CPB, measured in hours, as an adjustment variable. Temporal trends of CSat, cFTOE, RI, and PI were illustrated through graphs depicting the relationships between NIRS and TCD derived parameters. We conducted the statistical analyses using RStudio (Version 2023.09.1 + 494; Posit, PBC, Boston, MA).

RESULTS

Fifteen patients were included in the study of 37 infants admitted in our PICU after CPB between August 2021 and June 2022 (20 excluded due to absence of ultrasonographer and two declining participation; Fig. 1). CHD-type distribution is presented in Figure 1 and Supplemental Table 2 (https://links.lww.com/CCX/B598). With the exception of two participants, our cohort underwent biventricular repair. The average gestational age at birth was 37.9 weeks (± 1.9 wk). The median age at CPB was 75 days post-natal (IQR, 13–115 d), the median weight was 4900 g (IQR, 3500–5900 g). Among these individuals, 12 of 15 were males (80%).

Figure 1.

Figure 1.

Study flowchart. Flow diagram with participant inclusion and exclusion. Ao = aorta, AVo2 = arteriovenous oxygen difference, AVSD = atrioventricular septal defect, CHD = congenital heart disease, c-TGA = congenitally corrected transposition of the great arteries, d-TGA = dextro-transposition of the great arteries, NIRS = near-infrared spectroscopy, RV = right ventricle, Spo2 = peripheral oxygen saturation, TA = tricuspid atresia, TAPVR = total anomalous pulmonary venous return, TCD = transcranial color-coded duplex, TOF = tetralogy of Fallot, VSD = ventricular septal defect.

All our patients were treated prophylactically with milrinone (21). There were seven time points available for analysis with a mean time of 4.7 (sd, ± 1.2), 6.9 (± 0.9), 9.3 (± 1.7), 11.7 (± 2.1), 14.4 (± 2.7), 16.3 (± 1.8), and 19 (± 0.8) hours after the end of CPB. From 15 included patients, one passed away at 8.6 hours after admission (missing data after time point 4, univentricular physiology participant), we lost data of one participant after time point 4 due to ultrasound storing failure, four participants were extubated after time point 5 (missing data for time points 6 and 7), and one patient was extubated after time point 6 (missing data time point 7). Our final dataset included 87 data points of Spo2, CSat, CBFv, and AVo2 parameters obtained simultaneously.

Stability of Blood Flow Determinants

In our cohort, mean arterial blood pressure values ranged from 54 ± 9 mm Hg at time 1 (lowest values) to 59 ± 9 mm Hg at time 7 (highest values). Mean Paco2 values ranged from 36 ± 6 mm Hg at time 1 to 40 ± 5 mm Hg at time 7. Mean hemoglobin values ranged from 140 ± 17 g/L at time 1 to 141 ± 12 g/L at time 7 and mean rectal temperature values ranged from 35.8 ± 1.3°C to 36 ± 0.6°C. Overall, time trends of Paco2, hemoglobin, and temperature were stable in our cohort, outlining that their contribution to fluctuations in CBF is expected to be minimal (Table 1).

TABLE 1.

Near-Infrared Spectroscopy, Mean Cerebral Artery Doppler, and Clinical Parameters by Transcranial Doppler Time Point

Transcranial Doppler 1 2 3 4 5 6 7
Number of subjects 15 15 15 13 13 9 7
Hours post-bypass 4.7 (1.2) 6.9 (0.9) 9.3 (1.7) 11.7 (2.1) 14.4 (2.7) 16.3 (1.8) 19 (0.8)
Hemoglobin (g/L) 140 (17) 144 (19) 149 (17) 151 (13) 146 (13) 142 (14) 141 (12)
Oxygen saturation (%) 96 (7) 94 (8) 96 (7) 96 (6) 96 (6) 95 (8) 98 (2)
pH 7.41 (0.08) 7.42 (0.09) 7.38 (0.06) 7.42 (0.07) 7.40 (0.06) 7.38 (0.06) 7.36 (0.05)
Paco2 (mm Hg) 36 (6) 35 (6) 37 (4) 35 (4) 36 (3) 39 (5) 40 (5)
Lactate (mmol/L) 2.4 (1.6) 2 (1.2) 2 (1.4) 1.6 (0.9) 1.34 (0.6) 1.3 (0.6) 1.6 (0.6)
Arteriovenous oxygen difference (%) 0.34 (0.1) 0.38 (0.1) 0.37 (0.1) 0.35 (0.1) 0.33 (0.1) 0.31 (0.07) 0.26 (0.14)
Temperature (ºC) 35.8 (1.3) 36 (1.1) 36.1 (1.1) 36.2 (1.2) 36.2 (1.1) 36.3 (1.3) 36 (0.6)
Invasive systolic blood pressure 77 (15) 78 (17) 72 (13) 72 (8) 72 (9) 73 (11) 78 (12)
Invasive mean arterial pressure 54 (9) 59 (11) 57 (11) 57 (6) 56 (7) 55 (7) 59 (9)
Invasive diastolic blood pressure 51 (12) 52 (11) 48 (9) 48 (5) 47 (6) 45 (5) 48 (7)
State Behavioral Scale –2.3 (1) –1.9 (1.3) –1.9 (1.3) –1.8 (1) –1.5 (1.1) –1 (1.2) –0.5 (1)
Right CSat (%) 59 (11) 57 (9) 57 (11) 60 (8) 63 (6) 64 (8) 65 (8)
Left CSat (%) 62 (12) 59 (13) 60 (25) 60 (10) 64 (8) 66 (8) 62 (8)
Right FTOE (%) 38 (12) 39 (13) 41 (13) 37 (12) 34 (9) 32 (13) 33 (9)
Left FTOE (%) 35 (12) 37 (16) 37 (15) 36 (12) 33 (10) 28 (12) 35 (8)
Right PSV (cm/s) 68 (28) 65 (23) 65 (22) 65 (25) 73 (29) 84 (33) 92 (35)
Left PSV (cm/s) 70 (31) 68 (24) 66 (25) 69 (28) 77 (32) 89 (34) 99 (44)
Right MV (cm/s) 35 (14) 34 (11) 34 (12) 35 (12) 38 (14) 46 (20) 50 (23)
Left MV (cm/s) 35 (15) 35 (12) 34 (12) 37 (15) 41 (17) 48 (20) 54 (27)
Right EDV (cm/s) 18 (8) 18 (6) 18 (9) 20 (7) 24 (14) 27 (14) 28 (16)
Left EDV (cm/s) 18 (9) 18 (7) 18 (7) 21 (9) 23 (10) 28 (13) 32 (18)
Right RI-MCA 0.73 (0.06) 0.71 (0.07) 0.71 (0.09) 0.68 (0.07) 0.67 (0.09) 0.68 (0.06) 0,71 (0.09)
Left RI-MCA 0.74 (0.07) 0.72 (0.06) 0.71 (0.07) 0.69 (0.05) 0.69 (0.04) 0.69 (0.06) 0.70 (0.08)
Right PI-MCA 1.44 (0.26) 1.37 (0.26) 1.42 (0.48) 1.28 (0.24) 1.27 (0.14) 1.27 (0.23) 1.37 (0.36)
Left PI-MCA 1.48 (0.25) 1.42 (0.23) 1.39 (0.28) 1.28 (0.21) 1.3 (0.15) 1.31 (0.23) 1.32 (0.3)

CSat = cerebral saturation, EDV = end-diastolic velocity, FTOE = fractional tissue oxygen extraction, MV = mean velocity, PI-MCA = pulsatility index of mean cerebral artery, PSV = peak systolic velocity, RI-MCA = resistive index of mean cerebral artery.

Values are expressed as mean (sd).

The Effect of Time

The postsurgical time trends of right and left MCA CBFv, PI, RI, and CSat values are summarized in Table 1. For the right side, the mean CSat at time point 1 (4.7 hr post-bypass) was 59% ± 11%, reaching its lowest value at 9.3 hours post-bypass, then gradually increasing to a final average of 65% ± 8% at time point 7 (19 hr post-bypass). Right MCA CBFv followed a similar pattern, with PSV starting at 68 ± 28 cm/s, MV at 35 ± 14 cm/s, and EDV at 18 ± 8 cm/s. The lowest values occurred between 6.9 and 9.3 hours post-bypass, followed by a rise to PSV of 92 ± 35 cm/s, MV of 50 ± 23 cm/s, and EDV of 28 ± 18 cm/s. Right MCA RI was 0.73 ± 0.06 and PI was 1.48 ± 0.25 at time point 1 with no significant change at time point 7 (RI-MCA 0.71 ± 0.06 and PI-MCA 1.37 ± 0.36 with respective p values of 0.20 and 0.49). Right FTOE was 38% ± 12% at time point 1, peaked at 9.3 hours post-CPB and gradually decreased to 33% ± 9% at time point 7. Similar trends and values were observed in the left MCA. AVo2 difference peaked, exceeding 0.35, between 6.9 and 9.3 hours post-bypass. Graphical representations of these time trends are shown in Figure 2 and Supplemental Figures 2–4 in Appendix 1 (https://links.lww.com/CCX/B598).

Figure 2.

Figure 2.

Bilateral mean cerebral artery (MCA) Doppler trends over first 24 hr. Time 0 is the end of bypass. Trends over time for right and left MCA. EDV = end-diastolic velocity, MV = mean velocity, PSV = peak systolic velocity.

The mixed-effect model revealed a significant association between time in hours after the end of CPB and TCD velocities (PSV, MV, EDV), left CSat, and AVo2 as detailed in Supplemental Table 3 (https://links.lww.com/CCX/B598). For each hour after the end of CPB, right PSV increased by 1.43 cm/s (95% CI, 0.86–2 cm/s), left PSV increased by 1.68 cm/s (95% CI, 1.05–2.31 cm/s), right MV increased by 0.81 cm/s (95% CI, 0.46–1.17 cm/s), left MV increased by 1.05 cm/s (95% CI, 0.69–1.41 cm/s), right EDV increased by 0.61 cm/s (95% CI, 0.34–0.89 cm/s), and left EVD increased by 0.72 cm/s (95% CI, 0.46–0.99 cm/s). Left CSat increased by 0.54% every hour after the end of CPB (95% CI, 0.46–1.17), and right CSat did not show significance, but had a similar evolution, increasing over time by 0.47% per hour (95% CI, 0.265–0.678).

There was a significant association between AVo2 and MV, AVo2 and cFTOE, while accounting for the timing of evaluation since the end of CPB, as detailed in Table 2. The analysis indicated that, on average, an increase of 0.1 units in the AVo2 difference was associated with a decrease of 5.8 cm/s of right MCA MV (95% CI, –8 to –3,5), a decrease of 5.4 cm/s of the left MCA MV (95% CI, –8 to –2.8), an increase of 3.4% (95% CI, 2–4.9%) for right cFTOE, and an increase of 4% for the left cFTOE (95% CI, 2.2–5.8). The mixed-effect models for CSat and Doppler indices and cFTOE and Doppler indices, also shown in Table 2, are less significant and clinically less relevant.

TABLE 2.

Random Mixed-Effect Models: Association Between Near-Infrared Spectroscopy, Doppler Parameters, and Arteriovenous Oxygen Difference

Outcome Predictor Coefficient (95% CI) p
Right MV AVo2 –5.8 (–8 to –3.5) < 0.001
Left MV –5.4 (–8 to –2.8) < 0.001
Right FTOE AVo2 3.4 (2–4.9) < 0.001
Left FTOE 4 (2.2–5.8) < 0.001
Right CSat Right RI (*) –1.4 (–3.3 to 0.6) 0.172
Right PI (*) –0.5 (–1.1 to 0.01) 0.059
Left CSat Left RI –0.6 (–1.1 to –0.12) 0.016
Left PI –0.7 (–1.5 to –0.02) 0.047
Right FTOE Right RI 1.2 (–9.1 to 32.5) 0.27
Right PI 0.5 (0.04–1) 0.037
Left FTOE Left RI 0.7 (0.2–1.2) 0.008
Left PI 0.6 (–0.1 to 1.5) 0.11

AVo2 = arteriovenous oxygen difference, CSat = cerebral saturation, FTOE = fractional tissue oxygen extraction, MV = mean velocity, PI = pulsatility index, RI = resistive index

*RI and PI are expressed as 0.1 unit of increment or decrease.

In this table, the variable “Time” represents the time in hours since the end of bypass. Bolded values are statistically significant.

Figure 3 shows the graphical relationship between AVo2 and MV, as well as between AVo2 and FTOE. Lower MCA MV correlated with a higher AVo2 difference, with extremes observed at an AVo2 close to 0.5 when MV was around 20 cm/s, and an AVo2 of 0.2 when MV exceeded 80 cm/s. A right MV of 25.1 cm/s corresponded to an AVo2 value of 0.35 on the locally estimated scatterplot smoothing curve, while an MV of 23 cm/s corresponded to an AVo2 value of 0.40. Similarly, a left MV of 25.3 cm/s corresponded to an AVo2 value of 0.35, and an MV of 17.7 cm/s corresponded to an AVo2 value of 0.40. The graph shows three distinct zones: zone 1, where AVo2 is directly proportional to the decrease in MV from 30 to 20 cm/s; zone 2, where MV ranges between 30 and 45 cm/s and AVo2 stabilizes around 0.35–0.37; and zone 3, where further increases in MV (above 45 cm/s) result in a steady decline in AVo2. Regarding the AVo2/FTOE relationship, higher cFTOE corresponded with higher AVo2 values. There was a stable region around an FTOE of 40, where AVo2 remained around 0.35.

Figure 3.

Figure 3.

Correlations arteriovenous oxygen difference (AVo2)/mean velocity (MV) and AVo2/fractional tissue oxygen extraction (FTOE). The top outline the relationship between mean cerebral artery (MCA) MV and AVo2 for the right and left MCA. The bottom graphs represent the relationship between cerebral FTOE (cFTOE) and AVo2 difference bilaterally. A right MV of 25.1 cm/s corresponded to an AVo2 value of 0.35 on the locally estimated scatterplot smoothing curve, while an MV of 23 cm/s corresponded to an AVo2 value of 0.40. Similarly, a left MV of 25.3 cm/s corresponded to an AVo2 value of 0.35, and an MV of 17.7 cm/s corresponded to an AVo2 value of 0.40.

DISCUSSION

Our study analyzed seven time points and 87 data points (including of Spo2, CSat, CBFv, and AVo2) collected from 15 infants with CHD during the first 24 hours following CPB, a critical period of vulnerability regarding cerebral perfusion. Overall, there was a parallel evolution of CBFv and CSat with correlation of AVo2 and cFTOE and cerebral mean flow velocity.

Cerebral Saturation and Cerebral Blood Flow Velocities

During the first night after CPB, we observed that bilateral MCA CBFv, including PSV, MV, and EDV, followed a parallel pattern, decreasing from the time of PICU admission and reaching their lowest values between 6.9 and 9.3 hours post-CPB, followed by a steady increase from 9.3 to 24 hours. Interestingly, these findings compare to Wernovsky et al (2) results in neonates and infants after an arterial switch operation. Their team examined the hemodynamic profile, including cardiac index, pulmonary vascular resistance, and systemic vascular resistance, in 122 participants during the first postoperative night. In that study, the cardiac index decreased by 32.1% ± 15.4%, while pulmonary and systemic vascular resistance increased. A cardiac index of less than 2.0 L/min/m2 was observed in 24% of the patients, with the nadir typically occurring 9–12 hours post-surgery. Similarly, in our cohort, we noted the nadir of bilateral CBFv, CSat, and the peak of both cFTOE and AVo2 differences between 6.9 and 9.3 hours post-bypass. This suggests that the period of suboptimal cerebral perfusion likely occurs between 6 and 10 hours after CPB marking a critical window for monitoring and intervention. During this time window, cerebral hemodynamics could serve as a potential surrogate for CO. This information can guide brain-based goal-directed therapies, potentially optimize outcomes by mitigating neurologic risks. Further research is needed to explore the potential benefits of maneuvers such as vasopressors/inotropes titration to improve CO and enhance cerebral perfusion, adjust Paco2 targets, and reduce mean airway pressure to improve cerebral venous drainage. The higher PSV observed at time points 6 and 7 (16.3 and 19 hr post-CPB) could be a combination of higher CO and hyperemia. Further research is needed to understand the risk for acute brain injury in this scenario (e.g., reperfusion injury) and the possible need for intensivist to readjust hemodynamic therapies in this context.

CSat has been described to correlate with cerebral oxygen consumption (22) and variably correlate with CO in preterm neonates and pediatric cardiac population (2325), but not in term neonates during the transitional period (26). A retrospective study of 91 single ventricle infants below 6 months of age, a CSat of less than 57% at 6 hours post-CPB had 91% sensitivity and 72% specificity to detect LCOS (18). In postoperative sedated patients, cerebral oxygen consumption should remain stable in the absence of seizures, fever, new parenchymal brain disease, brain death, stable hemoglobin, and Co2 levels. The observed decreasing trend in CSat during the first 9.6 hours and in conjunction with decreasing trend of CBFv is likely associated with a lower CO related to myocardial dysfunction following CPB.

From Cerebral Doppler to Cerebral Blood Flow

During the 1990s, TCD began to be used with the aim of understanding CBFv, to provide information on cerebral perfusion, and correlating these measures with neurologic outcomes (11, 27, 28). Current scientific evidence is variable on the association between changes in CBF and MCA CBFv (29, 30). TCD now plays an essential role in multimodal neuromonitoring during CPB, allowing monitoring of CBF during circulatory arrest or low-flow states (9, 10). Additionally, both high and low CBFv during CPB have been shown to have diagnostic value for predicting postoperative cognitive dysfunction in adult patients, potentially helping to minimize postsurgical delirium (14, 31, 32). Although the behavior of CBFv after CPB is not well-studied, the same principles may apply. In our cohort, after ensuring stability of central body temperature, MAP, Co2, pH, and hemoglobin, we extrapolated that changes in CBFv reflect acute changes in CO, potentially with or without a component of cerebral vasodilation. We believe that the coincidence of the nadir in CBFv by TCD in the time window of low CO suggests a reduction in CBF in a population with often impaired cerebral autoregulation (33). The observed combination of increased FTOE and decreased NIRS during the first 6 to 10 hours post-CPB may further suggest a decrease in CO rather than cerebral vasodilation. Requiring further research, the identification of low brain perfusion due to low CO could trigger the intensivist to titrate hemodynamic resuscitation. Similarly, hemodynamic and ventilation therapies could be adjusted in case of evolution to high CO with cerebral hyperemia.

Cardio-Cerebral Coupling

Control of CBF is vital in managing critically ill cardiac patients. Although the link between CO and CBF is theoretically sound, consistent evidence is lacking (29). Our cohort’s findings—showing the timing of peak AVo2, peak cFTOE, and nadir CBFv and CSat coinciding with a known nadir in CO around 12 hours post-CPB (2)—suggest potential cardio-cerebral coupling. In addition, studies have shown that approximately 15% of children with CHD have impaired autoregulation post-surgically, making them more vulnerable to fluctuations in CO and at greater risk of cerebral hypoperfusion during perioperative periods (34).

Limitations

Several limitations may affect the generalizability of our findings. As a single-center study with a small sample size, extrapolation is limited. Two participants with univentricular physiology were included in this cohort. While their physiology differs from those with biventricular repairs, their inclusion was intended to reflect the diversity of the postoperative CHD population in the cardiac ICU. Nonetheless, this may introduce variability in CSat values and should be considered when interpreting the results. Importantly, the use of cFTOE in our analysis helps mitigate this variability by accounting for differences in systemic oxygen delivery and providing a more physiologically surrogate measure of cerebral oxygen extraction. The observational nature meant our single ultrasonographer was not blinded to CSat, which is routinely used in the PICU. Additionally, patient 1 had a premature death, and patient 13 lost data after time 5, potentially affecting the analysis. Regarding study’s strengths, our data were prospectively and rigorously acquired using a standardized protocol by one ultrasonographer. To our knowledge, this is the first study to provide new data on CSat and CBFv monitoring after CPB in infants before the arrival of robotic TCD.

CONCLUSIONS

Our cohort of CHD patients monitored post-CPB revealed a parallel evolution of CBFv and CSat with correlation of AVo2 with MV. CSat and CBFv have an earlier nadir (6–10 hr) compared with the previously published evolution of cardiac index in infants after CPB (9–12 hr). In the absence of direct CO monitoring in critically ill children, noninvasive cerebral oxygenation and blood flow monitoring could be an alternative method to measure LCOS. Further studies utilizing advanced bedside monitors and more sophisticated multimodal neuromonitoring platforms are essential to deepen our understanding of CBF dynamics following CPB and to guide brain-focused resuscitation strategies.

ACKNOWLEDGMENTS

We thank the cardiac intensive care nursing team at the Montreal Children’s Hospital for their disposition and collaboration.

Supplementary Material

cc9-8-e1364-s001.pdf (979.5KB, pdf)

Footnotes

This work was performed at Montreal Children’s Hospital, McGill University, Montreal, QC, Canada.

This study was approved by the institutional review board of the Montreal University Health Center.

The derived data generated in this research will be shared on reasonable request to the corresponding author.

The authors have disclosed that they do not have any potential conflicts of interest.

Dr. Mir conceptualized and designed the study, collected the data, extracted the data, analyzed the data, wrote the article, and adjusted the article according to the comments of the coauthors. Drs. Maitre, Roche Martínez, Dancea, and Bernier critically appraised the analysis and revised the article. Drs. Shemie, Fontela, and Zavalkoff conceptualized and designed the study, critically appraised the analysis, and revised the article. Drs. O’Brien and LaRovere conceptualized the study and reviewed the article for important intellectual content. Dr. Altit conceptualized and designed the study, analyzed data, critically appraised the analysis of the data, and critically reviewed the article for important intellectual content. All authors approved the final article as submitted and agree to be accountable for all aspects of the work.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccejournal).

Contributor Information

Guillaume Maitre, Email: guillaume.maitre@chuv.ch.

Adrian Dancea, Email: adrian.dancea@mcgill.ca.

Pierre-Luc Bernier, Email: pierre-luc.bernier@mcgill.ca.

Patricia Fontela, Email: patricia.fontela@mcgill.ca.

Samara Zavalkoff, Email: samara.zavalkoff@mcgill.ca.

Ana Roche Martínez, Email: aroche@tauli.cat.

Kerri L. LaRovere, Email: Kerri.LaRovere@childrens.harvard.edu.

Sam D. Shemie, Email: sam.shemie@mcgill.ca.

Gabriel Altit, Email: gabriel.altit@mcgill.ca.

REFERENCES

  • 1.Chandler HK, Kirsch R: Management of the low cardiac output syndrome following surgery for congenital heart disease. Curr Cardiol Rev 2016; 12:107–111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wernovsky G, Wypij D, Jonas RA, et al. : Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92:2226–2235 [DOI] [PubMed] [Google Scholar]
  • 3.Massé L, Antonacci M: Low cardiac output syndrome: Identification and management. Crit Care Nurs Clin North Am 2005; 17:375–383, x [DOI] [PubMed] [Google Scholar]
  • 4.Parr GV, Blackstone EH, Kirklin JW: Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation 1975; 51:867–874 [DOI] [PubMed] [Google Scholar]
  • 5.Trieu CT, Williams TM, Cannesson M, et al. : Babies and children at last: Pediatric cardiac output monitoring in the twenty-first century. Anesthesiology 2019; 130:671–673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Singh Y, Katheria AC, Vora F: Advances in diagnosis and management of hemodynamic instability in neonatal shock. Front Pediatr 2018; 6:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.O’Brien NF, Reuter-Rice K, Wainwright MS, et al. : Practice recommendations for transcranial Doppler ultrasonography in critically ill children in the pediatric intensive care unit: A multidisciplinary expert consensus statement. J Pediatr Intensive Care 2020; 10:133–142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Aaslid R, Markwalder TM, Nornes H: Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57:769–774 [DOI] [PubMed] [Google Scholar]
  • 9.Leth-Olsen M, Døhlen G, Torp H, et al. : Cerebral blood flow dynamics during cardiac surgery in infants. Pediatr Res 2025; 97:625–633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Polito A, Ricci Z, Di Chiara L, et al. : Cerebral blood flow during cardiopulmonary bypass in pediatric cardiac surgery: The role of transcranial Doppler—a systematic review of the literature. Cardiovasc Ultrasound 2006; 4:47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Venn GE, Patel RL, Chambers DJ: Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit. Ann Thorac Surg 1995; 59:1331–1335 [DOI] [PubMed] [Google Scholar]
  • 12.Haydin S, Onan B, Onan IS, et al. : Cerebral perfusion during cardiopulmonary bypass in children: Correlations between near-infrared spectroscopy, temperature, lactate, pump flow, and blood pressure. Artif Organs 2013; 37:87–91 [DOI] [PubMed] [Google Scholar]
  • 13.Mittnacht AJ, Rodriguez-Diaz C: Multimodal neuromonitoring in pediatric cardiac anesthesia. Ann Card Anaesth 2014; 17:25–32 [DOI] [PubMed] [Google Scholar]
  • 14.Vu EL, Brown CH, Brady KM, et al. : Monitoring of cerebral blood flow autoregulation: Physiologic basis, measurement, and clinical implications. Br J Anaesth 2024; 132:1260–1273 [DOI] [PubMed] [Google Scholar]
  • 15.Lovett ME, MacDonald JM, Mir M, et al. : Noninvasive neuromonitoring modalities in children part I: Pupillometry, near-infrared spectroscopy, and transcranial Doppler ultrasonography. Neurocrit Care 2024; 40:130–146 [DOI] [PubMed] [Google Scholar]
  • 16.Altun D, Doğan A, Arnaz A, et al. : Noninvasive monitoring of central venous oxygen saturation by jugular transcutaneous near-infrared spectroscopy in pediatric patients undergoing congenital cardiac surgery. Turk J Med Sci 2020; 50:1280–1287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Aly SA, Zurakowski D, Glass P, et al. : Cerebral tissue oxygenation index and lactate at 24 hours postoperative predict survival and neurodevelopmental outcome after neonatal cardiac surgery. Congenit Heart Dis 2017; 12:188–195 [DOI] [PubMed] [Google Scholar]
  • 18.Doctor P, Aggarwal S, Garcia R: Is there an association of near-infrared spectroscopy with low cardiac output and adverse outcomes in single-ventricle patients after stage 1 palliation? Ann Pediatr Cardiol 2022; 15:249–256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Alexandrov AV, Bennet J: Principles of transcranial Doppler sonography. In Neurovascular Sonography (pp. 1–31). Springer International Publishing AG. 2022, pp 1–31 [Google Scholar]
  • 20.Baik N, Urlesberger B, Schwaberger B, et al. : Reference ranges for cerebral tissue oxygen saturation index in term neonates during immediate neonatal transition after birth. Neonatology 2015; 108:283–286 [DOI] [PubMed] [Google Scholar]
  • 21.Hoffman TM, Wernovsky G, Atz AM, et al. : Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics. Am Heart J 2002; 143:15–21 [DOI] [PubMed] [Google Scholar]
  • 22.Zaramella P, Freato F, Quaresima V, et al. : Surgical closure of patent ductus arteriosus reduces the cerebral tissue oxygenation index in preterm infants: A near-infrared spectroscopy and Doppler study. Pediatr Int 2006; 48:305–312 [DOI] [PubMed] [Google Scholar]
  • 23.Pfurtscheller D, Wolfsberger CH, Höller N, et al. : Cardiac output and regional-cerebral-oxygen-saturation in preterm neonates during immediate postnatal transition: An observational study. Acta Paediatr 2023; 112:1404–1412 [DOI] [PubMed] [Google Scholar]
  • 24.Deshpande P, Barbosa de Olivera C, Jain A, et al. : Relationship between cerebral oxygenation, cardiac output, and blood pressure during transitional period in extremely low gestational age neonates. Front Pediatr 2023; 11:1187769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Absi MA, Lutterman J, Wetzel GT: Noninvasive cardiac output monitoring in the pediatric cardiac intensive care unit. Curr Opin Cardiol 2010; 25:77–79 [DOI] [PubMed] [Google Scholar]
  • 26.Baik-Schneditz N, Schwaberger B, Mileder L, et al. : Cardiac output and cerebral oxygenation in term neonates during neonatal transition. Children (Basel) 2021; 8:439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Burrows FA: Transcranial Doppler monitoring of cerebral perfusion during cardiopulmonary bypass. Ann Thorac Surg 1993; 56:1482–1484 [DOI] [PubMed] [Google Scholar]
  • 28.Zimmerman AA, Burrows FA, Jonas RA, et al. : The limits of detectable cerebral perfusion by transcranial Doppler sonography in neonates undergoing deep hypothermic low-flow cardiopulmonary bypass. J Thorac Cardiovasc Surg 1997; 114:594–600 [DOI] [PubMed] [Google Scholar]
  • 29.Castle-Kirszbaum M, Parkin WG, Goldschlager T, et al. : Cardiac output and cerebral blood flow: A systematic review of cardio-cerebral coupling. J Neurosurg Anesthesiol 2022; 34:352–363 [DOI] [PubMed] [Google Scholar]
  • 30.Patel K, Dan Y, Kunselman AR, et al. : The effects of pulsatile versus nonpulsatile flow on cerebral pulsatility index, mean flow velocity at the middle cerebral artery, regional cerebral oxygen saturation, cerebral gaseous microemboli counts, and short-term clinical outcomes in patients undergoing congenital heart surgery. JTCVS Open 2023; 16:786–800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bukauskienė R, Širvinskas E, Lenkutis T, et al. : The influence of blood flow velocity changes to postoperative cognitive dysfunction development in patients undergoing heart surgery with cardiopulmonary bypass. Perfusion 2020; 35:672–679 [DOI] [PubMed] [Google Scholar]
  • 32.Kasputytė G, Bukauskienė R, Širvinskas E, et al. : The effect of relative cerebral hyperperfusion during cardiac surgery with cardiopulmonary bypass to delayed neurocognitive recovery. Perfusion 2023; 38:1688–1696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Tran NN, Kumar SR, Hodge FS, et al. : Cerebral autoregulation in neonates with and without congenital heart disease. Am J Crit Care 2018; 27:410–416 [DOI] [PubMed] [Google Scholar]
  • 34.Nagaraj UD, Evangelou IE, Donofrio MT, et al. : Impaired global and regional cerebral perfusion in newborns with complex congenital heart disease. J Pediatr 2015; 167:1018–1024 [DOI] [PubMed] [Google Scholar]

Articles from Critical Care Explorations are provided here courtesy of Wolters Kluwer Health

RESOURCES